The nuclear overexpression of protein arginine methyltransferase-5 (PRMT5) was negatively associated with tumor grade, thus reflecting potential differences in the epigenetic control of oncogenesis of low- and high-grade lung NETs [54]. This evidence concerns the gene PRMT5 and lung neuroendocrine neoplasm.